XOMA - 31 Year Stock Price History | XOMA

Historical daily share price chart and data for XOMA since 1989 adjusted for splits. The latest closing stock price for XOMA as of January 28, 2020 is 23.36.
  • The all-time high XOMA stock closing price was 9595.20 on March 05, 1991.
  • The XOMA 52-week high stock price is 28.85, which is 23.5% above the current share price.
  • The XOMA 52-week low stock price is 11.54, which is 50.6% below the current share price.
  • The average XOMA stock price for the last 52 weeks is 18.16.
XOMA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 24.9000 27.6800 27.6800 22.8800 23.3600 -14.43%
2019 17.3011 13.2700 28.6600 11.8300 27.3000 115.81%
2018 21.2280 35.9200 35.9200 11.2700 12.6500 -64.47%
2017 12.5470 4.9700 36.7900 4.0300 35.6000 743.60%
2016 12.4726 26.8000 26.8000 4.2200 4.2200 -84.14%
2015 50.2669 71.0000 94.4000 14.4120 26.6000 -62.95%
2014 100.2528 138.4000 188.8000 68.6000 71.8000 -46.66%
2013 81.3167 51.8000 146.0000 50.2000 134.6000 180.42%
2012 53.9870 25.0000 79.0000 24.8000 48.0000 108.70%
2011 57.1240 106.0000 146.1000 22.0000 23.0000 -77.58%
2010 118.3450 209.8651 238.0810 45.6000 102.6000 -51.03%
2009 218.7597 200.8996 353.8231 113.9430 209.5352 12.71%
2008 601.4329 959.5202 959.5202 179.9100 185.9070 -81.71%
2007 933.1275 647.6762 1280.3598 602.6987 1016.4918 54.09%
2006 557.6432 500.7496 731.6342 476.7616 659.6702 37.50%
2005 481.9745 767.6162 767.6162 296.8516 479.7601 -38.22%
2004 1180.0909 2008.9955 2290.8546 587.7061 776.6117 -60.76%
2003 1811.7197 1202.3988 2944.5277 875.5622 1979.0105 56.03%
2002 1762.7817 2800.5997 3523.2384 929.2354 1268.3658 -57.06%
2001 3003.2173 2623.6882 5115.4423 1668.0660 2953.5232 1.03%
2000 2421.7213 890.2549 4536.7316 843.4783 2923.5382 225.00%
1999 1224.6198 1011.9940 2352.0240 618.5907 899.5502 -5.90%
1998 1216.8404 1705.5472 1836.5817 590.4048 955.9220 -42.69%
1997 1791.4643 1508.5457 2417.6912 1180.8096 1668.0660 8.44%
1996 1526.9343 1199.4003 2398.8006 937.0315 1538.2309 46.57%
1995 733.9937 815.2924 1180.8096 393.7031 1049.4753 30.21%
1994 1065.6691 1649.1754 1799.1004 674.6627 805.9970 -48.80%
1993 2021.4422 2998.5007 2998.5007 1499.2504 1574.2129 -45.45%
1992 4557.9159 6110.9445 7346.3268 2698.6507 2886.0570 -54.17%
1991 6760.4103 5997.0015 9595.2024 4272.8636 6296.8516 2.44%
1990 6053.3330 7085.4573 7796.1019 4647.6762 6146.9265 -5.75%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.204B $0.005B
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.596B 15.39
CSL (CSLLY) Australia $96.833B 0.00
Gilead Sciences (GILD) United States $81.425B 10.09
Vertex Pharmaceuticals (VRTX) United States $59.651B 60.88
Biogen (BIIB) United States $50.876B 8.73
Illumina (ILMN) United States $46.199B 50.69
Regeneron Pharmaceuticals (REGN) United States $37.778B 16.54
Alexion Pharmaceuticals (ALXN) United States $23.671B 11.69
Seattle Genetics (SGEN) United States $19.355B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Incyte (INCY) United States $16.469B 38.23
BioMarin Pharmaceutical (BMRN) United States $15.428B 0.00
Genmab (GNMSF) Denmark $13.600B 60.07
Alnylam Pharmaceuticals (ALNY) United States $12.790B 0.00
Galapagos (GLPG) Belgium $12.624B 32.53
Exact Sciences (EXAS) United States $11.777B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $9.724B 0.00
Sarepta Therapeutics (SRPT) United States $8.791B 0.00
Bio-Techne Corp (TECH) United States $8.325B 55.72
QIAGEN (QGEN) Netherlands $7.749B 25.26
BioNTech SE (BNTX) Germany $7.743B 0.00
Moderna (MRNA) United States $7.451B 0.00
Guardant Health (GH) United States $7.385B 0.00
Amarin (AMRN) Ireland $7.237B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.810B 17.31
ACADIA Pharmaceuticals (ACAD) United States $6.400B 0.00
Reata Pharmaceuticals (RETA) United States $5.885B 0.00
Ascendis Pharma (ASND) Denmark $5.730B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.472B 0.00
Exelixis (EXEL) United States $5.433B 15.28
Repligen (RGEN) United States $5.292B 95.91
Bluebird Bio (BLUE) United States $4.646B 0.00
China Biologic Products (CBPO) China $4.570B 25.74
Acceleron Pharma (XLRN) United States $4.214B 0.00
MorphoSys AG (MOR) Germany $4.105B 0.00
Adaptive Biotechnologies (ADPT) United States $3.866B 0.00
Mirati Therapeutics (MRTX) United States $3.565B 0.00
Immunomedics (IMMU) United States $3.546B 0.00
NeoGenomics (NEO) United States $3.527B 187.67
Zai Lab (ZLAB) China $3.214B 0.00
Blueprint Medicines (BPMC) United States $3.204B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.179B 0.00
MyoKardia (MYOK) United States $3.178B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.093B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.055B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.971B 0.00
Genmab (GMAB) Denmark $2.896B 5.97
Emergent Biosolutions (EBS) United States $2.878B 28.59
Halozyme Therapeutics (HALO) United States $2.846B 0.00
Alkermes (ALKS) Ireland $2.799B 0.00
UniQure (QURE) Netherlands $2.669B 0.00
Denali Therapeutics (DNLI) United States $2.385B 0.00
Amicus Therapeutics (FOLD) United States $2.293B 0.00
RA PHARMCTL INC (RARX) United States $2.223B 0.00
Arena Pharmaceuticals (ARNA) United States $2.201B 5.12
Myriad Genetics (MYGN) United States $2.160B 31.91
Epizyme (EPZM) United States $1.986B 0.00
Fate Therapeutics (FATE) United States $1.934B 0.00
Insmed (INSM) United States $1.850B 0.00
Akcea Therapeutics (AKCA) United States $1.770B 0.00
Arvinas (ARVN) United States $1.742B 0.00
Zymeworks (ZYME) Canada $1.715B 0.00
Alector (ALEC) United States $1.695B 0.00
Principia Biopharma (PRNB) United States $1.679B 0.00
REGENXBIO (RGNX) United States $1.602B 0.00
Ligand Pharmaceuticals (LGND) United States $1.546B 29.74
Editas Medicine (EDIT) United States $1.449B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.362B 0.00
Coherus BioSciences (CHRS) United States $1.325B 0.00
Intra-Cellular Therapies (ITCI) United States $1.320B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.286B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.275B 0.00
Zealand Pharma (ZEAL) Denmark $1.141B 0.00
Athenex (ATNX) United States $1.106B 0.00
DBV Technologies S.A (DBVT) France $1.022B 0.00
Revance Therapeutics (RVNC) United States $1.008B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.988B 0.00
Mesoblast (MESO) Australia $0.970B 0.00
Codexis (CDXS) United States $0.963B 0.00
PHARMA MAR SA (PHMMF) Spain $0.958B 0.00
Pharming Group (PHGUF) Netherlands $0.869B 0.00
Sangamo Therapeutics (SGMO) United States $0.842B 0.00
Heska (HSKA) United States $0.811B 207.14
ZIOPHARM Oncology Inc (ZIOP) United States $0.795B 0.00
Twist Bioscience (TWST) United States $0.794B 0.00
Vericel (VCEL) United States $0.750B 279.50
ANI Pharmaceuticals (ANIP) United States $0.742B 12.65
Vanda Pharmaceuticals (VNDA) United States $0.734B 6.17
Cytokineticsorporated (CYTK) United States $0.730B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Cellectis S.A (CLLS) France $0.700B 0.00
Adverum Biotechnologies (ADVM) United States $0.689B 0.00
Retrophin (RTRX) United States $0.687B 0.00
Sorrento Therapeutics (SRNE) United States $0.680B 0.00
GENFIT S.A (GNFT) France $0.670B 0.00
NantKwest (NK) United States $0.660B 0.00
Intellia Therapeutics (NTLA) United States $0.657B 0.00
Cara Therapeutics (CARA) United States $0.649B 0.00
Anika Therapeutics (ANIK) United States $0.645B 20.93
UROGEN PHARMA (URGN) United States $0.628B 0.00
AC Immune SA (ACIU) Switzerland $0.595B 13.75
Kadmon Holdings (KDMN) United States $0.589B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.553B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Prothena (PRTA) Ireland $0.540B 0.00
Cel-Sci (CVM) United States $0.510B 0.00
Agenus (AGEN) United States $0.509B 0.00
Bellus Health (BLU) Canada $0.504B 0.00
BioDelivery Sciences (BDSI) United States $0.494B 0.00
Precision BioSciences (DTIL) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Clovis Oncology (CLVS) United States $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.443B 0.00
Inovio Pharmaceuticals (INO) United States $0.436B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.415B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.404B 0.00
Merus (MRUS) Netherlands $0.402B 0.00
AnaptysBio (ANAB) United States $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.396B 0.00
Avid Bioservices (CDMO) United States $0.375B 0.00
Cue Biopharma (CUE) United States $0.372B 0.00
Compugen (CGEN) Israel $0.370B 0.00
PDL BioPharma (PDLI) United States $0.369B 9.23
Kindred Biosciences (KIN) United States $0.361B 0.00
Mersana Therapeutics (MRSN) United States $0.359B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.356B 2.46
Pfenex (PFNX) United States $0.354B 0.00
OSMOTICA PHARM (OSMT) United States $0.348B 0.00
CytomX Therapeutics (CTMX) United States $0.345B 0.00
Gritstone Oncology (GRTS) United States $0.336B 0.00
Stemline Therapeutics (STML) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Puma Biotechnology (PBYI) United States $0.325B 0.00
MannKind (MNKD) United States $0.322B 0.00
Syros Pharmaceuticals (SYRS) United States $0.308B 0.00
Albireo Pharma (ALBO) United States $0.308B 0.00
POXEL SA FRANCE (PXXLF) France $0.303B 0.00
IVERIC Bio (ISEE) United States $0.296B 0.00
Starpharma Holdings (SPHRY) Australia $0.286B 0.00
Geron (GERN) United States $0.270B 0.00
Kamada (KMDA) Israel $0.265B 7.73
WAVE Life Sciences (WVE) Singapore $0.258B 0.00
ChromaDex (CDXC) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.252B 0.00
VBI Vaccines (VBIV) United States $0.251B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Sutro Biopharma (STRO) United States $0.239B 0.00
Prometic Life Sciences (LMNL) Canada $0.236B 0.00
Novavax (NVAX) United States $0.230B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.222B 0.00
Athersys (ATHX) United States $0.221B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
Theratechnologies (THTX) Canada $0.219B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.214B 0.00
Affimed (AFMD) Germany $0.212B 0.00
Exicure (XCUR) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Protagonist Therapeutics (PTGX) United States $0.201B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Cerecor (CERC) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Aptinyx (APTX) United States $0.186B 0.00
Five Prime Therapeutics (FPRX) United States $0.185B 0.00
Fortress Biotech (FBIO) United States $0.174B 0.00
CorMedix Inc (CRMD) United States $0.174B 0.00
TELA Bio (TELA) United States $0.173B 0.00
Windtree Therapeutics (WINT) United States $0.172B 0.00
Arbutus Biopharma (ABUS) Canada $0.171B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.171B 8.77
Strongbridge Biopharma (SBBP) United States $0.170B 4.55
Alcobra (ARCT) United States $0.164B 0.00
Palatin Technologies (PTN) United States $0.162B 4.41
ARAVIVE, INC (ARAV) United States $0.156B 0.00
Dyadic (DYAI) United States $0.155B 0.00
PHASEBIO PHARMA (PHAS) United States $0.151B 0.00
Clearside Biomedical (CLSD) United States $0.139B 0.00
Selecta Biosciences (SELB) United States $0.138B 0.00
Verastem (VSTM) United States $0.137B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Applied Genetic Technologies (AGTC) United States $0.132B 0.00
Menlo Therapeutics (MNLO) United States $0.132B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Vaccinex (VCNX) United States $0.124B 0.00
Happiness Biotech Group (HAPP) China $0.122B 0.00
Northwest Biotherapeutics (NWBO) United States $0.120B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
VTv Therapeutics (VTVT) United States $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.116B 0.00
OvaScience (MLND) United States $0.115B 0.00
Arsanis (XFOR) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Liquidia Technologies (LQDA) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.103B 0.00
Acorda Therapeutics (ACOR) United States $0.101B 0.00
Proteostasis Therapeutics (PTI) United States $0.090B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Synlogic (SYBX) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Catalyst Biosciences (CBIO) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.078B 5.03
Prima BioMed (IMMP) Australia $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.058B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Curis (CRIS) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
AmpliPhi Biosciences (ARMP) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Celsion (CLSN) United States $0.034B 0.00
BioCardia (BCDA) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.032B 0.00
Bionano Genomics (BNGO) United States $0.030B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Oncobiologics (OTLK) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Stellar Biotechnologies (EDSA) Canada $0.026B 0.00
VIVUS (VVUS) United States $0.024B 0.00
AEterna Zentaris (AEZS) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
Advaxis (ADXS) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
BioPharmX (BPMX) United States $0.011B 0.00
IBio (IBIO) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00